1.70
+0.12(+7.59%)
Currency In USD
Previous Close | 1.58 |
Open | 1.56 |
Day High | 1.76 |
Day Low | 1.46 |
52-Week High | 3.26 |
52-Week Low | 0.87 |
Volume | 137,371 |
Average Volume | 113,212 |
Market Cap | 67.35M |
PE | -1.6 |
EPS | -1.06 |
Moving Average 50 Days | 1.86 |
Moving Average 200 Days | 2.11 |
Change | 0.12 |
If you invested $1000 in TELA Bio, Inc. (TELA) since IPO date, it would be worth $127.34 as of August 18, 2025 at a share price of $1.7. Whereas If you bought $1000 worth of TELA Bio, Inc. (TELA) shares 5 years ago, it would be worth $125 as of August 18, 2025 at a share price of $1.7.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire Inc.
Jul 23, 2025 8:03 PM GMT
MALVERN, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in
TELA Bio to Announce Second Quarter 2025 Financial Results
GlobeNewswire Inc.
Jul 21, 2025 8:03 PM GMT
MALVERN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will re
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Jun 06, 2025 8:05 PM GMT
MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by priori